FDA inspection
BDR Pharmaceuticals International Private, Ltd.: FDA inspection ending Nov 20, 2025
FDA inspection 1292028 · Halol
Key facts
| Inspection ID | 1292028 |
|---|---|
| Firm | BDR Pharmaceuticals International Private, Ltd. |
| FEI number | 3030526918 |
| Address | District Panchmahal, Ground Floor Injectable Manufacturing Unit; Post Taj; General Block |
| City | Halol |
| Fiscal year | 2026 |
| Inspection end date | Nov 20, 2025 |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data